Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-14

Clinical Trial Update: HFNC in Management of Bronchiectasis Exacerbation

View source ↗

Summary

A clinical trial is recruiting to evaluate high-flow nasal cannula therapy for bronchiectasis exacerbations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • High-Flow Nasal Cannula (HFNC) Therapy

Snippet

Sponsor: Assiut University | Conditions: Bronchiectasis | Status: RECRUITING